Axsome Therapeutics, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2026 Annual Meeting of Stockholders held on June 5, 2026. The filing details the voting outcomes for three key proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Of the 51,439,952 shares entitled to vote, 43,777,536 shares (approximately 85.10%) were represented at the meeting, constituting a quorum. The results for the proposals were as follows:
- Proposal 1 (Election of Class II Directors): Mark Saad and Susan Mahony, Ph.D., MBA, were elected.
- Mark Saad: 28,675,654 votes for; 10,286,822 votes withheld.
- Susan Mahony: 29,892,131 votes for; 9,070,345 votes withheld.
- Proposal 2 (Ratification of Auditors): Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026.
- Votes For: 43,278,147
- Votes Against: 14,407
- Votes Abstaining: 484,982
- Proposal 3 (Executive Compensation): The compensation of named executive officers was approved on a non-binding advisory basis.
- Votes For: 37,818,384
- Votes Against: 777,937
- Votes Abstaining: 366,155
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For further details on the proposals, the filing references the definitive proxy statement on Schedule 14A filed on April 24, 2026.
Key Facts for Investor Verification
- Verify the specific terms of the director elections and the tenure of the newly elected Class II directors (until the 2029 annual meeting).
- Review the Schedule 14A Proxy Statement filed on April 24, 2026, for detailed rationale behind the executive compensation package approved in Proposal 3.
- Note the significant number of broker non-votes (4,815,060) recorded for the director election and executive compensation proposals.
- Confirm the appointment of Deloitte & Touche LLP as the auditor for the fiscal year ending December 31, 2026.